Placing Statistics - February 2016

In February 2016, the Company raised £5.0 million before expenses through a Placing in order to help achieve the following objectives:

• to fund growth through acquisition by accelerating the Company’s consolidation strategy
• for working capital to enhance organic growth, for example, to accelerate the roll-out of the Group’s submit™ product and associated services as a result of the US Food & Drug Administration making it mandatory to use the Standard for the Exchange of Nonclinical Data ("SEND").

Number of Existing Ordinary Shares	13,043,774
Placing Price	200 pence
Number of New Ordinary Shares to be issued by the Company pursuant to the Placing	2,500,000
Number of Ordinary Shares in issue immediately following Admission	15,543,774
New Ordinary Shares as a percentage of the Enlarged Share Capital	16.1 per cent
Total gross proceeds of the Placing receivable by the Company	£5.0 million
Estimated net proceeds of the Placing receivable by the Company	£4.7 million

Placing Statistics - October 2010

In October 2010, the Company raised £9.15 million before expenses through a Placing and Admission to trading on AIM in order to help achieve the following objectives:

• raise and provide access to funds to facilitate growth through continuing M&A strategy;
• provide share based incentive structures that will attract, retain and incentivise the executive management team;
• increase the profile of the Group and enhance its reputation within its market; and
• provide the opportunity for founders to realise a proportion of their investment in the business.

Issue Price	175p
Number of Ordinary Shares in issue prior to the Placing	6,485,910
Number of Placing Shares being placed on behalf of the Group	5,228,376
Percentage of enlarged share capital being placed	44.6%
Number of Ordinary Shares in issue following Admission	11,714,286
Estimated gross proceeds of the Placing receivable by the Group	£9.15 million
Estimated net proceeds of the Placing receivable by the Group	£8.33 million
Market capitalisation of the Group at the Issue Price	£20.5 million
EPIC Code	INS.L